Skip to Main Content
The first stop for professional medicines advice

Colistimethate sodium: informing intrathecal risk assessment

Published Last updated See all updates
Topics: Aseptic servicesColistimethateInfection and infectious diseasesIntrathecal medicines

Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Contents
  1. Licensed for intrathecal use
    1. Hikma Farmacêutica
    2. Noridem
    3. SGS Pharma Magyarország
    4. Teva (Colomycin®)
  3. No information available
  4. Update history

Licensed for intrathecal use

Products licensed for intrathecal use are the first line option and should be used wherever suitable.

Hikma Farmacêutica

Strength

1 million International Units (IU)
2 million International Units (IU)

Noridem

Strength

1 million International Units (IU)
2 million International Units (IU)

SGS Pharma Magyarország

Strength

1 million International Units (IU)
2 million International Units (IU)

Teva (Colomycin®)

Strength

1 million International Units (IU)
2 million International Units (IU)

No information available

Products with very little or no information are rarely used for intrathecal administration.

There are currently no known additional colistimethate sodium products.

Update history

  1. Republished
  1. Full review of monograph.
  1. Title and URL shortened.
  1. Updated links
  1. Published

Print this page